Influenza A H1N1, External Run Control, Medium (6 x 1mL)
- Product Type: Control
- Volume: 1.0mL
- Units/Pack: 6
- Storage Condition: 2-8°C
- Hazardous Information: Non-Infectious
- Matrix: Purified protein matrix treated with 0.09% sodium azide
- Target: 25 to 28 Ct
- Product Type: Control
-
Classification/ Permits:
RUO
Learn MoreXFor Research Use Only. Not for use in Diagnostic Procedures.
Description
ZeptoMetrix external quality controls and verification panels, have demonstrated performance on a variety of molecular platforms. Based upon the platform and assay’s product configuration, including but not limited to fill volumes and concentrations of analytes, we recommend our NATtrol Influenza A H1N1, External Run Control, Medium (6 x 1mL) to be used in conjunction with the Focus Simplexa™ system or a real-time PCR thermal cycler.
- Formulated with purified, intact organisms
- Organisms are chemically modified to render them noninfectious
- Refrigerator stable—store between 2 and 8°C
- Purified protein matrix treated with 0.09% sodium azide
- 6 x 1.0 mL vials
- Target: 25 to 28 cycle threshold
Intended Use
NATtrol Influenza A H1N1, External Run Control, Medium (6 x 1mL) products are ready-to-use, inactivated full-process controls designed to evaluate the performance of molecular tests. They can be used for verification of assays, training laboratory personnel, and monitoring assay-kit lot performance. NATtrol Influenza A H1N1, External Run Control, Medium (6 x 1mL) products contain intact organisms and should be run in a manner similar to clinical specimens.
Limitations
For Research Use Only. Not for use in diagnostic procedures. Quality control materials should be used in accordance with local, state, federal, and accreditation requirements. This product is not intended to replace the manufacturer's controls provided with the assay. Propagation or commercialization are prohibited without prior written consent from Antylia Scientific.
When used as a control for nucleic acid tests, the same protocols as those used to amplify extracted clinical specimens should be employed.
The suitability and performance characteristics should be determined by your laboratory for each intended usage.